ES2191960T3 - Composiciones farmaceuticas que contienen un par acido-base efervescente. - Google Patents

Composiciones farmaceuticas que contienen un par acido-base efervescente.

Info

Publication number
ES2191960T3
ES2191960T3 ES98941377T ES98941377T ES2191960T3 ES 2191960 T3 ES2191960 T3 ES 2191960T3 ES 98941377 T ES98941377 T ES 98941377T ES 98941377 T ES98941377 T ES 98941377T ES 2191960 T3 ES2191960 T3 ES 2191960T3
Authority
ES
Spain
Prior art keywords
acid
efervescent
tablets
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98941377T
Other languages
English (en)
Inventor
Paolo Chiesi
Paolo Ventura
Rosa Mezzadri
Gaetano Brambilla
Daniela Acerbi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Application granted granted Critical
Publication of ES2191960T3 publication Critical patent/ES2191960T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica que se presenta en forma de comprimidos efervescentes que comprende un principio activo y una mezcla efervescente, comprendiendo esta mezcla efervescente un componente ácido y carbonato de glicina sódica como componentes alcalinos. El constituyente ácido preferido puede ser ácido fumárico, ácido maleico así como sus sales. Los comprimidos se preparan por compresión directa en condiciones de calor y de higrometría normales y con el equipamiento habitual para producir comprimidos.
ES98941377T 1997-07-23 1998-07-23 Composiciones farmaceuticas que contienen un par acido-base efervescente. Expired - Lifetime ES2191960T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Publications (1)

Publication Number Publication Date
ES2191960T3 true ES2191960T3 (es) 2003-09-16

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98941377T Expired - Lifetime ES2191960T3 (es) 1997-07-23 1998-07-23 Composiciones farmaceuticas que contienen un par acido-base efervescente.

Country Status (27)

Country Link
US (1) US6284272B1 (es)
EP (1) EP1003486B1 (es)
JP (1) JP4801255B2 (es)
KR (1) KR100528141B1 (es)
CN (1) CN1138535C (es)
AT (1) ATE232092T1 (es)
AU (1) AU743186B2 (es)
BG (1) BG64074B1 (es)
BR (1) BR9801335B1 (es)
CZ (1) CZ296221B6 (es)
DE (1) DE69811236T2 (es)
DK (1) DK1003486T3 (es)
EA (1) EA002608B1 (es)
ES (1) ES2191960T3 (es)
HK (1) HK1029525A1 (es)
HU (1) HU226115B1 (es)
IL (1) IL134166A (es)
IT (1) IT1293764B1 (es)
NO (1) NO326639B1 (es)
NZ (1) NZ502479A (es)
OA (1) OA10999A (es)
PL (1) PL199164B1 (es)
PT (1) PT1003486E (es)
SI (1) SI1003486T1 (es)
SK (1) SK284551B6 (es)
TR (1) TR199900675T1 (es)
WO (1) WO1999004765A2 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
US6956029B1 (en) * 1999-07-02 2005-10-18 Sca Lohnherstellungs Ag Solid formulation of glucosamine sulphate
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
IN190018B (es) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
JP2004506680A (ja) * 2000-08-18 2004-03-04 ファルマシア・コーポレーション シクロオキシゲナーゼ−２阻害剤の迅速崩壊経口製剤
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
ATE541575T1 (de) 2002-03-06 2012-02-15 Effrx Pharmaceuticals Sa Brausetabletten, enthaltend alendronat
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
PL2260871T3 (pl) 2004-04-01 2013-10-31 Pf Medicament Kompleksy inkluzyjne zawierające piroksykam, cyklodekstrynę i argininę
AU2005247048B2 (en) * 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1901720A2 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Improved dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普（保定）生物药业有限公司 一种饮水免疫泡腾片及其制备方法
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008079404A2 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
WO2008140772A2 (en) * 2007-05-08 2008-11-20 Hercules Incorporated Robust rapid disintegration tablet formulation
CA2711014C (en) 2007-12-28 2018-10-23 Impax Laboratories, Inc. Controlled release formulations of levodopa and uses thereof
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
BRPI0916344A2 (pt) 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
WO2011114239A2 (en) * 2010-03-13 2011-09-22 Eastpond Laboratories Limited Fat-binding compositions
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
CA2894272A1 (en) * 2012-12-14 2014-06-19 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
CA2926082C (en) 2013-10-07 2022-06-14 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP2870961B1 (en) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of pramipexole
EP3758754A1 (en) 2018-03-02 2021-01-06 Chiesi Farmaceutici S.p.A. A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
ATE76747T1 (de) * 1986-06-10 1992-06-15 Chiesi Farma Spa Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
CH675537A5 (es) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
ATE108649T1 (de) * 1990-02-14 1994-08-15 Takeda Chemical Industries Ltd Brausemischung, deren herstellung sowie verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung

Also Published As

Publication number Publication date
DE69811236T2 (de) 2003-10-30
SK922000A3 (en) 2000-07-11
BG64074B1 (bg) 2003-12-31
HK1029525A1 (en) 2001-04-06
PL338502A1 (en) 2000-11-06
KR20010022140A (ko) 2001-03-15
HUP0003897A3 (en) 2006-06-28
OA10999A (en) 2001-11-07
US6284272B1 (en) 2001-09-04
ATE232092T1 (de) 2003-02-15
IL134166A (en) 2005-08-31
DK1003486T3 (da) 2003-05-19
BR9801335A (pt) 1999-05-04
WO1999004765A3 (en) 1999-06-10
PT1003486E (pt) 2003-06-30
KR100528141B1 (ko) 2005-11-15
BG103253A (en) 1999-09-30
HUP0003897A2 (hu) 2001-08-28
AU8977798A (en) 1999-02-16
SI1003486T1 (en) 2003-08-31
PL199164B1 (pl) 2008-08-29
EP1003486A2 (en) 2000-05-31
CZ296221B6 (cs) 2006-02-15
JP4801255B2 (ja) 2011-10-26
EA200000062A1 (ru) 2000-10-30
ITMI971746A1 (it) 1999-01-23
CZ2000255A3 (cs) 2000-07-12
NO991376L (no) 1999-05-25
TR199900675T1 (xx) 1999-11-22
EP1003486B1 (en) 2003-02-05
AU743186B2 (en) 2002-01-17
CN1138535C (zh) 2004-02-18
BR9801335B1 (pt) 2010-09-21
NO326639B1 (no) 2009-01-26
IT1293764B1 (it) 1999-03-10
EA002608B1 (ru) 2002-06-27
CN1267215A (zh) 2000-09-20
WO1999004765A2 (en) 1999-02-04
NZ502479A (en) 2002-02-01
JP2001510789A (ja) 2001-08-07
HU226115B1 (en) 2008-04-28
NO991376D0 (no) 1999-03-22
DE69811236D1 (de) 2003-03-13
SK284551B6 (sk) 2005-06-02
IL134166A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
ES2191960T3 (es) Composiciones farmaceuticas que contienen un par acido-base efervescente.
AR038527A1 (es) Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo
DE69626117D1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
DOP2001000241A (es) Formulaciones de liberación sostenida para secretagogos de hormona del crecimiento
PA8559501A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno
AR018829A1 (es) Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos
SV2008002612A (es) Forma de dosificacion de liberacion retardada oral altamente biodisponibles de succionado de o-desmetilvanlafaxina ref. am101721salvo
UY32624A (es) Procedimiento y composición para mejorar la absorción de agentes terapéuticos
CO5540295A2 (es) Comprimido para tragar que comprende paracetamol
DE602004003577D1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
CO5160272A1 (es) Combinacion de cerivastatina y fibratos
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
CO4830457A1 (es) Preparados efervescentes
WO2003028624A3 (en) Levothyroxine compositions and methods
WO2004014318A3 (en) Levothyroxine compositions and methods
DK0768896T3 (da) Lavdoserede steroidtabletter, der indeholder gallussyreestere som antioxidant, fremgangsmåde til fremstilling og anvendelse
AR021719A1 (es) Composicion farmaceutica oral antiestrogenica.
MX2023005639A (es) Comprimidos de capa doble orales que comprenden acido acetilsalicilico y pseudoefedrina, metodos para preparar y utilizar los mismos.
AR043129A1 (es) Combinacion de farmacos antidiabeticos
BR0207299A (pt) Composição farmacêutica, solução aquosa e métodos para fabricar e para preparar uma composição, para instruir um humano a ingerir uma composição farmacêutica de liberação imediata e para tratar um humano
AR046666A1 (es) Composiciones farmaceuticas estabilizadas con carbonato de calcio
UY27624A1 (es) Composiciones farmacéuticas de mesilato de zoniporida y procedimientos para mejorar la solubilidad de la zoniporida
ECSP982731A (es) Inhibidores de benzotiazol de la proteina tirosina cinasa